SERPINE1 (which encodes for PAI1) is a prognostic marker of poor clinical outcomes in breast cancer patients44,45, has pro-tumorigenic roles46, and is upregulated when triple-negative breast cancer cells transition from epithelial to a mesenchymal state47. This evidence concerns the gene SERPINE1 and breast cancer.